Astrazeneca Phar

{
  "main_header": {
    "sid": 777011,
    "name": "Astrazeneca Phar",
    "stock_name": "Astrazeneca Phar",
    "full_name": "Astrazeneca Pharma India Ltd",
    "name_url": "stocks-analysis/astrazeneca-phar",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "6,706.00",
    "chg": 42.1,
    "chgp": "0.63%",
    "dir": 1,
    "prev_price": "6,663.90",
    "mcapval": "16,625.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 506820,
    "symbol": "ASTRAZEN",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE203A01020",
    "curr_date": "Sep 22, 03:32 PM",
    "curr_time": "15:40 PM",
    "last_traded_at": "Sep 22, 03:32 PM IST",
    "bse_nse_vol": "4.67 k",
    "exc_status": "Active",
    "traded_date": "Sep 22, 2026",
    "traded_date_str": "2026 09 22",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/astrazeneca-phar-777011-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Astrazeneca Pharma India Ltd Falls to 52-Week Low of Rs 6606.3 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/astrazeneca-pharma-india-ltd-falls-to-52-week-low-of-rs66063-4201400",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/AstrazenecaPhar_priceRelatedfactors_4201400.png",
        "date": "2026-09-22 11:35:45",
        "description": "A sustained decline has pushed Astrazeneca Pharma India Ltd to a fresh 52-week low of Rs 6606.3 on 22 Sep 2026, marking a significant 32.9% drop from its 52-week high of Rs 9850. The stock has underperformed its sector and the broader market, reflecting a complex interplay of valuation pressures and mixed financial signals."
      },
      {
        "title": "Astrazeneca Pharma India Ltd Falls to 52-Week Low of Rs 6610 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/astrazeneca-pharma-india-ltd-stock-hits-52-week-low-at-rs6610-4196983",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/AstrazenecaPhar_priceRelatedfactors_4196983.png",
        "date": "2026-09-18 09:45:24",
        "description": "A sustained decline has pushed Astrazeneca Pharma India Ltd to a fresh 52-week low of Rs 6610 on 18 Sep 2026, marking a significant 32.8% drop from its 52-week high of Rs 9850. This underperformance comes amid a broader market that is showing signs of resilience, highlighting a divergence that warrants closer examination."
      },
      {
        "title": "Astrazeneca Pharma India Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/astrazeneca-pharma-india-ltd-is-rated-sell-4193381",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/AstrazenecaPhar_mojoScore_4193381.png",
        "date": "2026-09-15 10:10:29",
        "description": "Astrazeneca Pharma India Ltd is rated Sell by MarketsMOJO, with this rating last updated on 02 January 2026. However, the analysis and financial metrics presented here reflect the stock’s current position as of 15 September 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Astrazeneca Pharma India Ltd Falls to 52-Week Low of Rs 6,736 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/astrazeneca-pharma-india-ltd-stock-falls-to-52-week-low-of-rs6736-4193061",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/AstrazenecaPhar_priceRelatedfactors_4193061.png",
        "date": "2026-09-15 09:55:06",
        "description": "For the third consecutive session, Astrazeneca Pharma India Ltd has seen its share price decline, culminating in a fresh 52-week low of Rs 6,736 on 15 Sep 2026. This marks a significant 31.6% drop from its 52-week high of Rs 9,850, underscoring persistent selling pressure despite a broadly stable market backdrop."
      },
      {
        "title": "Astrazeneca Pharma India Ltd Falls to 52-Week Low of Rs 6780 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/astrazeneca-pharma-india-ltd-stock-hits-52-week-low-at-rs6780-4190116",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/AstrazenecaPhar_priceRelatedfactors_4190116.png",
        "date": "2026-09-11 09:46:33",
        "description": "For the second consecutive session, Astrazeneca Pharma India Ltd has slipped further, hitting a fresh 52-week low of Rs 6780 on 11 Sep 2026, extending its downward trajectory amid broader market weakness."
      },
      {
        "title": "Astrazeneca Pharma India Ltd Falls to 52-Week Low Amidst Profit Declines and Valuation Concerns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/astrazeneca-pharma-india-ltd-stock-falls-to-52-week-low-amidst-market-downturn-4188107",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/AstrazenecaPhar_priceRelatedfactors_4188107.png",
        "date": "2026-09-09 10:43:42",
        "description": "Astrazeneca Pharma India Ltd has edged to within a hair’s breadth of its 52-week low, closing at Rs 6,815.3 on 09 Sep 2026, marking a significant 25.15% decline over the past year. This downturn contrasts sharply with the broader market’s more modest losses, underscoring company-specific pressures that have weighed heavily on the stock."
      },
      {
        "title": "Astrazeneca Pharma India Ltd Falls to 52-Week Low of Rs 6815.3 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/astrazeneca-pharma-india-ltd-stock-falls-to-52-week-low-of-rs68153-4185247",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/AstrazenecaPhar_priceRelatedfactors_4185247.png",
        "date": "2026-09-07 15:05:44",
        "description": "Astrazeneca Pharma India Ltd has slipped to a fresh 52-week low of Rs 6815.3, extending its recent downward trajectory amid broader market weakness and company-specific pressures. This decline marks a significant 30.8% drop from its 52-week high of Rs 9850, underscoring the challenges facing the stock despite pockets of operational strength."
      },
      {
        "title": "Astrazeneca Pharma India Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/astrazeneca-pharma-india-ltd-is-rated-sell-4182507",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/AstrazenecaPhar_mojoScore_4182507.png",
        "date": "2026-09-04 10:10:05",
        "description": "Astrazeneca Pharma India Ltd is rated Sell by MarketsMOJO, with this rating last updated on 02 January 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 04 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Astrazeneca Pharma India Ltd Falls to 52-Week Low of Rs 6850 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/astrazeneca-pharma-india-ltd-falls-to-52-week-low-of-rs6850-4179277",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/AstrazenecaPhar_priceRelatedfactors_4179277.png",
        "date": "2026-09-02 09:53:25",
        "description": "For the eleventh consecutive session, Astrazeneca Pharma India Ltd has closed lower, culminating in a fresh 52-week low of Rs 6850 on 2 Sep 2026. This persistent decline has dragged the stock down by over 10% in less than three weeks, sharply underperforming both its sector and the broader market indices."
      }
    ],
    "total": 399,
    "sid": "777011",
    "stock_news_url": "https://www.marketsmojo.com/news/astrazeneca-pharma-india-777011"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order",
      "datetime": "18-Sep-2026",
      "details": "Please find the enclosed intimation of the Company with respect to the captioned subject for your reference.",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "15-Sep-2026",
      "details": "Please find the enclosed intimation of the Company as per the captioned subject for your reference.",
      "source": "BSE"
    },
    {
      "caption": "Information Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Resignation Of Senior Management Personnel",
      "datetime": "15-Sep-2026",
      "details": "Please find the enclosed intimation of the Company in relation to the captioned subject for your reference.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Astrazeneca Pharma India Ltd has declared <strong>1800%</strong> dividend, ex-date: 31 Jul 26",
          "dt": "2026-07-31",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Astrazeneca Pharma India Ltd has announced <strong>2:10</strong> stock split, ex-date: 15 Jun 06",
          "dt": "2006-06-15",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Astrazeneca Pharma India Ltd Falls to 52-Week Low of Rs 6606.3 as Sell-Off Deepens

2026-09-22 11:35:45

A sustained decline has pushed Astrazeneca Pharma India Ltd to a fresh 52-week low of Rs 6606.3 on 22 Sep 2026, marking a significant 32.9% drop from its 52-week high of Rs 9850. The stock has underperformed its sector and the broader market, reflecting a complex interplay of valuation pressures and mixed financial signals.

Read full news article

Astrazeneca Pharma India Ltd Falls to 52-Week Low of Rs 6610 as Sell-Off Deepens

2026-09-18 09:45:24

A sustained decline has pushed Astrazeneca Pharma India Ltd to a fresh 52-week low of Rs 6610 on 18 Sep 2026, marking a significant 32.8% drop from its 52-week high of Rs 9850. This underperformance comes amid a broader market that is showing signs of resilience, highlighting a divergence that warrants closer examination.

Read full news article

Astrazeneca Pharma India Ltd is Rated Sell

2026-09-15 10:10:29

Astrazeneca Pharma India Ltd is rated Sell by MarketsMOJO, with this rating last updated on 02 January 2026. However, the analysis and financial metrics presented here reflect the stock’s current position as of 15 September 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Astrazeneca Pharma India Ltd Falls to 52-Week Low of Rs 6,736 as Sell-Off Deepens

2026-09-15 09:55:06

For the third consecutive session, Astrazeneca Pharma India Ltd has seen its share price decline, culminating in a fresh 52-week low of Rs 6,736 on 15 Sep 2026. This marks a significant 31.6% drop from its 52-week high of Rs 9,850, underscoring persistent selling pressure despite a broadly stable market backdrop.

Read full news article

Astrazeneca Pharma India Ltd Falls to 52-Week Low of Rs 6780 as Sell-Off Deepens

2026-09-11 09:46:33

For the second consecutive session, Astrazeneca Pharma India Ltd has slipped further, hitting a fresh 52-week low of Rs 6780 on 11 Sep 2026, extending its downward trajectory amid broader market weakness.

Read full news article

Astrazeneca Pharma India Ltd Falls to 52-Week Low Amidst Profit Declines and Valuation Concerns

2026-09-09 10:43:42

Astrazeneca Pharma India Ltd has edged to within a hair’s breadth of its 52-week low, closing at Rs 6,815.3 on 09 Sep 2026, marking a significant 25.15% decline over the past year. This downturn contrasts sharply with the broader market’s more modest losses, underscoring company-specific pressures that have weighed heavily on the stock.

Read full news article

Astrazeneca Pharma India Ltd Falls to 52-Week Low of Rs 6815.3 as Sell-Off Deepens

2026-09-07 15:05:44

Astrazeneca Pharma India Ltd has slipped to a fresh 52-week low of Rs 6815.3, extending its recent downward trajectory amid broader market weakness and company-specific pressures. This decline marks a significant 30.8% drop from its 52-week high of Rs 9850, underscoring the challenges facing the stock despite pockets of operational strength.

Read full news article

Astrazeneca Pharma India Ltd is Rated Sell

2026-09-04 10:10:05

Astrazeneca Pharma India Ltd is rated Sell by MarketsMOJO, with this rating last updated on 02 January 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 04 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Astrazeneca Pharma India Ltd Falls to 52-Week Low of Rs 6850 as Sell-Off Deepens

2026-09-02 09:53:25

For the eleventh consecutive session, Astrazeneca Pharma India Ltd has closed lower, culminating in a fresh 52-week low of Rs 6850 on 2 Sep 2026. This persistent decline has dragged the stock down by over 10% in less than three weeks, sharply underperforming both its sector and the broader market indices.

Read full news article

View All News